Q3 2018 Holdings
Filed 2018-11-13 | 44 holdings | $391.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | ADR | 04351P101 | $153.5M | 2,166,832 | 39.2% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common | 22663K107 | $108.6M | 3,792,169 | 27.7% |
| Codexis, Inc.(CDXS) | Common | 192005106 | $47.2M | 2,749,343 | 12.0% |
| Arrowhead Pharmaceuticals In(ARWR) | Common | 04280A100 | $44.6M | 2,328,475 | 11.4% |
| Aclaris Therapeutics(ACRS) | Common | 00461U105 | $23.9M | 1,647,214 | 6.1% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $8.1M | 1,213,290 | 2.1% |
| Arvinas Holding Co LLC(ARVN) | Common | 04335A105 | $5.1M | 300,000 | 1.3% |
| Biohaven Pharmaceutical Holding Company Ltd(BHVN) | Common | G11196105 | $77.0K | 2,049,545 | 0.0% |
| Sinovac Biotech Ltd(SVA) | SHS | P8696W104 | $45.0K | 5,900,000 | 0.0% |
| Amyris, Inc.(AMRSEUR) | Common | 03236M200 | $44.3K | 5,575,118 | 0.0% |
| Menlo Therapeutics | Common | 586858102 | $39.5K | 4,011,236 | 0.0% |
| Kadmon Holdings (Kdmn)(KDMN) | Common | 48283N106 | $34.9K | 10,454,545 | 0.0% |
| Tricida, Inc.(1T7) | Common | 89610F101 | $30.3K | 991,711 | 0.0% |
| KalVista Pharmaceuticals, Inc.(KALV) | Common | 483497103 | $30.1K | 1,359,149 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $26.5K | 1,159,742 | 0.0% |
| MEI Pharma Inc (NAS) | Common | 55279B202 | $24.9K | 5,778,106 | 0.0% |
| Apellis Pharmaceuticals, Inc.(APLS) | Common | 03753U106 | $24.1K | 1,354,554 | 0.0% |
| Eiger BioPharmaceuticals(CLDNEUR) | Common | 28249U105 | $21.5K | 1,791,257 | 0.0% |
| Verona Pharma Plc(VRNA) | ADS | 925050106 | $18.7K | 1,492,951 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $18.6K | 1,405,476 | 0.0% |
| Nabriva Therapeutics Plc | SHS | G63637105 | $17.9K | 6,619,190 | 0.0% |
| Acer Therapeutics Inc(OPXAEUR) | Common | 00444P108 | $17.4K | 565,579 | 0.0% |
| Obseva SA | Common | H5861P103 | $16.9K | 937,147 | 0.0% |
| Selecta Biosciences, Inc.(SELBUSD) | Common | 816212104 | $11.8K | 761,253 | 0.0% |
| Galmed Pharmaceuticals Ltd(GLMD) | SHS | M47238106 | $11.6K | 851,492 | 0.0% |
| Kala Pharmaceuticals, Inc. | Common | 483119103 | $10.3K | 1,043,020 | 0.0% |
| Cymabay Therapeutics inc(CBAYUSD) | Common | 23257D103 | $10.0K | 906,000 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $9.7K | 620,134 | 0.0% |
| Soleno Therapeutics, Inc. | Common | 834203200 | $9.4K | 4,359,683 | 0.0% |
| Deciphera Pharmaceuticals In(DCPHEUR) | Common | 24344T101 | $8.2K | 212,648 | 0.0% |
| Kiniksa Pharmaceuticals | Common | G5269C101 | $6.8K | 264,878 | 0.0% |
| Genocea Biosciences Inc(NMS) | Common | 372427104 | $6.4K | 8,180,000 | 0.0% |
| Zogenix, Inc. | Common | 98978L204 | $5.2K | 105,000 | 0.0% |
| Zai Lab LTD(ZLAB) | ADR | 98887Q104 | $4.5K | 231,010 | 0.0% |
| Strongbridge Biopharma plc | SHS USD | G85347105 | $4.5K | 918,132 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U107 | $4.1K | 2,438,270 | 0.0% |
| Trevena, Inc. | Common | 89532E109 | $3.7K | 1,728,000 | 0.0% |
| BioPharmX Corporation | Common | 09072X101 | $3.1K | 16,128,515 | 0.0% |
| Foamix Pharmaceuticals Ltd. | SHS | M46135105 | $2.5K | 427,500 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $885 | 345,850 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $555 | 1,513,975 | 0.0% |
| Sunesis Pharmaceuticals, Inc. | Common Par | 867328700 | $391 | 195,474 | 0.0% |
| GTX Inc | Common | 40052B207 | $165 | 105,043 | 0.0% |
| Soleno Therapeutics, Inc. | Warrant | 834203135 | $23 | 188,772 | 0.0% |